Huntington's disease-like 2

被引:4
|
作者
Margolis, R. L. [1 ]
Rudnicki, D. D. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol,Lab Genet Neurobiol, CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA
关键词
D O I
10.1007/978-3-540-71693-8_5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease like-2 (HDL2) is an autosomal dominant disorder that clinically and pathologically closely resembles Huntington's disease (HD). Like HD, HDL2 is characterized by mid-life onset, abnormalities of voluntary and involuntary movement, psychiatric syndromes, and dementia, with a relentless progress to death. The disease is rare, and thus far has only been detected in individuals of African ancestry. Striatal and cortical atrophy is prominent, as are intranuclear protein aggregates. Some, but not all, affected individuals have acanthocytosis. HDL2 is caused by a CAG/CTG expansion mutation on chromosome 16q24.3, in an alternatively spliced exon of junctophilin-3. The mechanism of HDL2 pathogenesis is uncertain, but may involve the toxic properties of mutant transcripts containing expanded CUG repeats.
引用
收藏
页码:59 / +
页数:4
相关论文
共 50 条
  • [1] The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease
    Ferreira-Correia, Aline
    Krause, Amanda
    Anderson, David G.
    [J]. JOURNAL OF HUNTINGTONS DISEASE, 2020, 9 (04) : 325 - 334
  • [2] The Neuropsychiatric Manifestations of Huntington's Disease-Like 2
    Fischer, Christopher A.
    Licht, Eliot A.
    Mendez, Mario F.
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 24 (04) : 489 - 492
  • [3] Huntington's disease-like 2: Clinical features
    Walker, RH
    Margolis, RL
    [J]. MOVEMENT DISORDERS, 2005, 20 (12) : 1675 - 1676
  • [4] Phenotypic features of Huntington's disease-like 2
    Walker, RH
    Jankovic, J
    O'Hearn, E
    Margolis, RL
    [J]. MOVEMENT DISORDERS, 2003, 18 (12) : 1527 - 1530
  • [5] Huntington's disease-like 2 in South Africa
    Greenberg, Jacquie
    Bardien, Soraya
    Carr, Jonathan
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2008, 98 (03): : 166 - 166
  • [6] Huntington's disease-like 2: a phenocopy not to miss
    De Oliveira, Daniel Sabino
    Santos, Daniela Pereira
    Araujo, Daniel Oliveira
    Tomaselli, Pedro Jose
    Marques Junior, Wilson
    Vale, Thiago Cardoso
    [J]. PRACTICAL NEUROLOGY, 2020, 20 (06): : 479 - 481
  • [7] Huntington's disease and Huntington's disease-like syndromes: an overview
    Goevert, Felix
    Schneider, Susanne A.
    [J]. CURRENT OPINION IN NEUROLOGY, 2013, 26 (04) : 420 - 427
  • [8] Huntington's disease-like 2 and apparent ancestry
    Rodrigues, G. G. R.
    Teive, H. A. G.
    Tumas, V.
    [J]. CLINICAL GENETICS, 2009, 75 (02) : 207 - 207
  • [9] Huntington's disease-like 2: a clinical, pathological, and molecular comparison to Huntington's disease
    Margolis, RL
    Holmes, SE
    [J]. CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 187 - 196
  • [10] A comparison of Huntington disease and Huntington disease-like 2 neuropathology
    Rudnicki, Dobrila D.
    Pletnikova, Olga
    Vonsattel, Jean-Paul G.
    Ross, Christopher A.
    Margolis, Russell L.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (04): : 366 - 374